US 8912316
Compositions and methods for inhibiting expression of CD45 gene
granted A61PA61P25/00A61P31/12
Quick answer
US patent 8912316 (Compositions and methods for inhibiting expression of CD45 gene) held by The Government of the United States, as Respresented by the Secretary of the Army expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States, as Respresented by the Secretary of the Army
- Grant date
- Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P25/00, A61P31/12, A61P31/14, A61P31/16